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Purpose: The aim of this study was to evaluate the expression of the protein annexin A1 (ANXA1), a potent endogenous
regulator of the inflammatory process, in ocular toxoplasmosis.
Methods: C57BL/6 female mice were infected using intravitreal injections of either 106 tachyzoites of Toxoplasma
gondii (RH strain; T. gondii) or PBS only (control groups). After 24, 48, and 72 h, animals were sacrificed and their eyes
were  harvested  for  histopathological,  immunohistochemical,  and  ultrastructural  immunocytochemical  analysis  of
ANXA1. Human retinal pigment epithelial (RPE) cells (ARPE-19) were infected in vitro with T. gondii and collected
after 60, 120, 240 min, and 24 h.
Results: Compared with non-infected eyes, an intense inflammatory response was observed in the anterior (24 h after
infection) and posterior segments (72 h after infection) of the infected eye, characterized by neutrophil infiltration and by
the presence of tachyzoites and their consequent destruction along with disorganization of normal retina architecture and
RPE vacuolization. T. gondii infection was associated with a significant increase of ANXA1 expression in the neutrophils
at 24, 48, and 72 h, and in the RPE at 48 and 72 h. In vitro studies confirmed an upregulation of ANXA1 levels in RPE
cells, after 60 and 120 min of infection with T. gondii.
Conclusions: The positive modulation of endogenous ANXA1 in the inflammatory and RPE cells during T. gondii
infection suggests that this protein may serve as a therapeutic target in ocular toxoplasmosis.
Retinochoroiditis is the most common manifestation of
ocular toxoplasmosis and is often the only clinical symptom
of congenital toxoplasmosis [1,2]. This condition can also
induce inflammation in the iris, ciliary body and cataracts
[3].  In  active  ocular  toxoplasmosis  the  choroid  exhibits
vascular changes, hemorrhage, inflammatory infiltrates, and
edema, which may cause optic neuritis [4,5].
Experimental  assays  using  animals  to  investigate  the
effects of Toxoplasma gondii (T. gondii) in the eye have been
important for a better understanding of the pathogenesis of
human  ocular  toxoplasmosis.  The  macrophages,
lymphocytes,  plasma  cells,  and  mast  cells  that  infiltrate
infectious lesions, are detected mainly around blood vessels,
and  release  potent  inflammatory  mediators,  including
histamine,  in  particular,  which  contributes  to  ocular
inflammatory processes [6]. Mast cells are highly specialized
cells  that  synthesize  and  secrete  a  variety  of
pharmacologically  active  products  present  in  their
cytoplasmic  granules,  including  acid  phosphatase,
peroxidase, beta-glucuronidase, RNase, DNase, and anionic
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proteins that give their classical staining patterns [7]. After
mast cell degranulation, these associated factors can trigger
chemotaxis and the transmigration of leukocytes to the sites
of tissue injury [8].
In addition to inflammatory cells, the retinal pigment
epithelium (RPE) plays important roles in the inflammatory,
immune and healing processes during ocular inflammation in
the  immunosuppression  of  lymphocyte  proliferation  and
activation of macrophages by prostaglandin production and
transforming  growth  factor  beta  (TGF-β)  secretion,
respectively [9].
Recent studies have elucidated that in addition to cellular
activation induced by pharmacological mediators and pro-
inflammatory  pathways  during  the  parasitic  infection,  the
immune response is also partially attributed to other systems
that  modulate  the  inflammatory  events.  One  of  the
endogenous  inflammatory  mediators  that  is  induced  by
glucocorticoids and that is responsible for the inhibition of
eicosanoid and phospholipase A2 synthesis is the annexin A1
protein (ANXA1) [10]. In addition to its anti-inflammatory
activities,  ANXA1  is  involved  in  other  pathways  of
inflammation, such as the potentiation of apoptosis [11,12]
and the inhibition of necrosis induced by hydrogen peroxide
in rat thymocytes [13].
The expression of ANXA1 was detected in several tissues
and  cell  types,  including  neutrophils  [14,15],  monocytes
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1583[16], mast cells [17,18], and epithelial cells [19]. However,
the increased expression of this protein may occur during a
systemic inflammatory reaction, such as that observed in an
experimental  model  of  lipopolysaccharide  (LPS)-induced
endotoxaemia [20]. This model demonstrated that ANXA1
expression depends on the combined actions of endogenous
glucocorticoids,  interleukin  6  (IL-6)  and  tumor  necrosis
factor-α (TNF-α). Furthermore, studies demonstrated that the
ANXA1  protein  critically  regulates  acute  and  systemic
inflammation  induced  by  zymosan  and  LPS,  respectively
[21,22].
Despite these findings, the role of ANXA1 in the eye
remains  relatively  unstudied.  This  study  evaluated  the
expression  of  ANXA1  in  the  ocular  tissues  of  mice
intravitreally  infected  with  T.  gondii  (RH  strain)  and
investigated  parasite/host  cells  interactions  in  vitro  using
ARPE-19 cells.
METHODS
Animals:  Four-  to  six-week-old  female  C57BL/6  mice
(bodyweight  15  to  18  g)  were  obtained  from  the  animal
facilities of the Oswaldo Cruz Foundation, Rio de Janeiro,
Brazil. The animals were fed commercial chow and water ad
libitum, and were maintained in a 12 h light/dark cycle. All
experiments  were  performed  in  accordance  with  the
guidelines  for  experimental  procedures  of  Oswaldo  Cruz
Foundation (process number L.0228/04).
Parasites:  T.  gondii  tachyzoites  of  the  RH  strain  were
maintained  by  serial  passage  in  female  Swiss  mice.  For
experimental infections, tachyzoites were obtained from the
peritoneal exudates of mice, which were washed twice in1640
RPMI (Sigma, St. Louis, MO) containing 50 mg/l gentamicin.
The  viable  parasites  were  counted  in  a  Neubauer
hemocytometer  chamber  in  suspensions  containing  trypan
blue.
Experimental design: Animals were divided into 2 groups of
12 animals each and were inoculated by intravitreal injection
of 106 tachyzoites in 5 µl of PBS (experimental group) or by
5 µl of PBS alone (control group) [23]. Four animals from
each group were killed at 24, 48, and 72 h post-infection in a
CO2 chamber. The eyes were enucleated, fixed and processed
for  histopathological,  immunohistochemical  and
immunocytochemical analysis as described below.
ARPE-19  culture  conditions:  Retinal  pigment  cells
(ARPE-19), isolated from a human eye in 1986 [24] were
purchased  from  ATCC  (register  number  CRL2302;
Manassas, VA). ARPE-19 cells were maintained in 25 cm2
tissue culture flasks containing 5 ml of Dullbecco’s Modified
Eagle’s medium and Ham F-12 (DMEM-F12; D5523; Sigma-
Aldrich, Dublin, Ireland), supplemented with 10% fetal calf
serum (SFB; CULTILAB, Campinas, SP, BR), 200 mM L-
glutamine (G5792; Sigma-Aldrich) and 100 U/ml of penicillin
(P7794; Sigma-Aldrich), and incubated at 37 °C under 5% of
atmosphere CO2.
ARPE-19  cell  infection  of T.  gondii:  For  the  infection
experiments,  cells  were  cultured  in  25  cm2  tissue  culture
flasks, at 37 °C, in a 5% CO2 atmosphere, for 24 h before
infection  with  T.  gondii  tachyzoites  at  a  ratio  of  10:1
(parasites:cell) and monitored by phase contrast microscopy.
After various periods of time (60, 120, 240 min, and 24 h after
infection), cells were collected and fixed as described below.
Non-infected cells were used as controls.
Fixation,  processing,  and  embedding  for  light  and
transmission electron microscopy: The eyes and ARPE-19
cells  were  fixed  in  4%  paraformaldehyde,  0.5%
glutaraldehyde, and 0.1 mol/l sodium cacodylate buffer (pH
7.4) for 24 h at 4 °C, washed in sodium cacodylate, dehydrated
through graded percentages of methanol, and embedded in
LRGold (London Resin Co., Reading, UK). Sections (1 µm
thick)  were  stained  with  1%  toluidine  blue  in  1%  borax
solution  (TAAB  Laboratories,  Aldermaston,  UK).  Eye
sections were analyzed on an Axioskop 2-Mot Plus Zeiss
microscope (Carl Zeiss, Jena, Germany) for histopathological
analysis  and  quantification  of  neutrophils  and  mast  cells.
Values  are  shown  as  mean±standard  error  (SE)  of  cells
number per mm2 of four sections (1 µm) per sample (five
samples per animal).
Immunohistochemical studies: LR Gold-embedded sections
(1 µm thick) were incubated with 10% bovine albumin in PBS
(PBSA)  to  block  nonspecific  binding.  Slides  were  then
incubated  overnight  at  4  °C  with  polyclonal  rabbit  anti-
ANXA1 antibody (1/200 in 1% PBSA; Zymed, Cambridge,
UK). As a control for the reaction, rabbit pre-immune serum
(1/200 working dilution; Sigma-Aldrich) was applied in place
of  the  primary  antibody.  After  repeated  washings  in  1%
PBSA, a goat anti-rabbit IgG (Fc fragment-specific) antibody
conjugated to 5 nm colloidal gold (1/100; BBInternational,
Cardiff,  UK)  was  applied.  Silver-enhancing  solution
(BBInternational) was used to augment gold particle staining.
At the end of the reaction, sections were washed thoroughly
in  distilled  water,  counterstained  with  hematoxylin,  and
mounted in BIOMOUNT (BBInternational). Densitometric
analysis for the ANXA1 immunostaining was performed to
an arbitrary scale ranging from 0 to 255 using AxioVision
software on a Zeiss-Axioskop 2 light microscope, and the data
are presented as mean±SEM.
Ultrastructural immunocytochemistry (transmission electron
microscopy): Ultrathin sections (70 nm) of eye tissues were
incubated  as  follows:  (1)  in  phosphate-buffered  solution
(PBS) containing 1% egg albumin (PBEA) for 10 min and
then (2) in PBS containing 5% egg albumin (PBEA) for 30
min. The sections were then incubated in either polyclonal
rabbit anti-ANXA1 (1:200; Zymed) or in normal rabbit serum
as a control for 2 h. After washes in PBEA, a goat anti-rabbit
IgG antibody (1:100 in PBEA) conjugated to 15 nm colloidal
gold (British Biocell, Cardiff, UK) was applied, and after 1 h,
sections were washed in PBEA and then in distilled water.
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citrate  before  examination  on  a  ZEISS  EM900  electron
microscope  (Department  of  Morphology  and  Genetics,
UNIFESP).
Randomly  photographed  sections  of  retinal  pigment
epithelium were used for immunocytochemical analysis. The
area  of  the  cell  compartment  was  determined  with
AxioVision software. The density of immunogold (number of
gold particles per µm2) was calculated and expressed for each
cell compartment. Values are reported as mean±SEM of ten
electronmicrographs analyzed per group.
Statistical  analysis: Statistical  differences  between  groups
were determined by ANOVA followed, if significant, by the
Bonferroni test. In all cases a p-value less than 0.05 was
considered as significant.
RESULTS
Histopathological analysis of ocular tissues after T. gondii
infection: Histopathological analysis of the anterior segment
of  the  eye  from  control  and  tachyzoites  infected  animals
showed  an  intense  inflammatory  response  at  24  h  after
infection, characterized by neutrophil transmigration into the
tissues,  particularly  in  the  cornea.  At  48  and  72  h  after
infection a decrease in the influx of these cells was noted
(Table 1).
In the posterior segment of the non-infected (control;
Figure 1A-C) and infected eyes (Figure 1D-I), the intravitreal
injection  caused  morphological  changes  in  the  retina
characterized by its detachment (Figure 1A,E,F) as well as
gaps  in  the  outer  segments  of  the  photoreceptors  (Figure
1B,C,H) and folds of the outer nuclear and plexiform layers
directed toward the vitreous chamber (Figure 1F). Despite
these non-specific effects, the destruction and disruption of
the normal retinal architecture in eyes that were intravitreally
inoculated with tachyzoites were more severe compared to
control  eyes  Please  spell  out  the  full  name  the  first  time
mentioned in the text.
At  24,  48,  and  72  h  post-infection,  histopathological
analysis  of  the  ocular  tissues  revealed  the  presence  of
inflammatory infiltrates, including in particular neutrophils
and  mast  cells  (Figure  1G),  and  tachyzoites  (Figure  1H).
These  cells  exhibited  intravascular  and  extravaseted
localization in the choroid, inner ganglionar and plexiform
layers, as well as in the humor vitreous (Figure 1I). After 72
h  of  parasite  inoculation,  the  quantitative  analysis  of
inflammatory  cells  showed  a  significant  increase  in  the
neutrophil population in the posterior segment, particularly in
the retina, as compared to other experimental groups (Table
1).
In addition to neutrophils, mast cells were also observed
in the anterior and posterior segments of the eye, including,
in particular, the limbus and sclera. Morphological analysis at
24 and 48 h after infection showed a decrease in the mast cell
population  in  the  eyes  (11.5±0.5  and  12.5±4.8  cells/mm2,
respectively),  as  compared  to  the  control  animals
(23.75±12.29 and 27.2±8.95; p>0.05). In the latter phase of
infection (72 h), no difference in mast cell distribution was
detected between the control and experimental groups (10±10
and 12.3±3.6 cells/mm2, p>0.05, respectively). At this time
point, degranulated mast cells were detected in the anterior
segments of infected eyes.
Effect of T. gondii infection on ANXA1 expression in the eye:
ANXA1 expression was analyzed by immunohistochemistry
and ultrastructural immunocytochemistry using a polyclonal
antibody,  which  detects  the  intact  (37  kDa)  and  cleaved
(33 kDa) forms of the protein. Immunohistochemical studies
showed that neutrophils were immunoreactive for ANXA1 in
the ocular tissues of both the control and experimental groups
at different time points (24, 48, and 72 h). The neutrophils of
parasite-inoculated eyes exhibited a strong immunoreactivity
for  ANXA1  compared  to  the  neutrophils  of  control  eyes
(Figure  2A-F).  Densitometric  analysis  confirmed  our
histological data, which exhibited a significant increase in the
expression of ANXA1 in the neutrophils of T. gondii-infected
TABLE 1. QUANTITATIVE ANALYSIS OF NEUTROPHILS IN THE ANTERIOR AND POSTERIOR SEGMENTS OF THE EYE.
  Segments of eye
Time/Group Anterior Posterior
24 h/Control 226±212.2 50±35.6
24 h/Experimental 1327±679.5 115±63.6
48 h/Control 5±5 5±2.6
48 h/Experimental 913.3±471.2** 484±236
72 h/Control 10.33±5.5 3.6±2.7
72 h/Experimental 735±115.8* 4472±1405*
        Animals were intravitreally inoculated with 106 tachyzoites in 5 μl of BS (experimental group) or with 5 μl of PBS alone (control
        group), and the eyes were collected 24, 48,and 72 h after infection. Tissue preparation was performed as described in Methods.
        Values are displayed as the mean±SEM of tissues analyzed from 4 mice/group. *p<0.01 and **p<0.001 versus the respective
        control group.
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1585Figure 1. Histopathological analysis of ocular tissues in T. gondii infection. Control group (A-C). Experimental group (D-I). Disruption of
normal retina architecture, formation of gaps (*; B, C, E, and H), retinal detachment (hollow curved arrow; A, E, and F) and the presence of
inflammatory cells (arrows) in control and experimental groups after 24, 48, and 72 h. Mast cell (filled curved arrow) in sclera region (G).
Blood vessel (v). Stain: Toluidine blue. Scale bars: 50 μm (A-F), 10 μm (G-I).
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1586eyes at 24, 48, and 72 h after initial infection as compared to
the respective control groups (Figure 2G).
Transmission electron microscopy was used to evaluate
the expression of ANXA1 in the retinal pigment epithelium
(RPE), a tissue that plays an important role in immune defense
against  T.  gondii  infection.  The  RPE  is  located  between
vessels  of  the  choriocapillaris  and  light-sensitive  outer
segments of the photoreceptors (Figure 3A). The posterior
segment of the eye was significantly affected by T. gondii
infection after 24, 48, and 72 h, as previously described, and
exhibited a marked vacuolization of RPE cells (Figure 3D) as
compared  to  the  control  group  (Figure  3B).  ANXA1
immunogold labeling was detected in the RPE of control and
infected eyes, with localization in the cytosol, vacuoles and
membrane of pigment granules (Figure 3C,E,F,G). T. gondii
infection  produced  in  the  RPE  a  significant  increase  of
ANXA1 immunoreactivity in their subcellular compartments
(plasma membrane, cytoplasm and nucleus) at 48 and 72 h
(Figure 3F,G), compared to control group, that was confirmed
by quantification of gold particles (Figure 3I). No labeling was
detected in the control section (Figure 3H).
Analysis  of  ANXA1  expression  in  human  retinal  pigment
epithelial cells (ARPE-19) after T. gondii in vitro infection:
Upon detection of ANXA1 in the RPE, we performed in vitro
studies using ARPE-19 cells to investigate the modulation of
ANXA1 expression after T. gondii infection.
Initially, ARPE-19 cells were analyzed by phase contrast
microscopy  during  control  conditions  that  allow  for  the
retention of features characteristic of the RPE, including well
defined cell borders and noticeable pigmentation. After T.
gondii  infection,  ARPE-19  cells  exhibited  morphological
alterations,  including  cytoplasmic  retraction  and  the
formation of long and thin extensions with increased presence
of intracellular parasites, particularly 60 and 240 min after
initial  infection  (Figure  4A-C).  The  morphological  and
structural alterations associated with T. gondii infection were
confirmed by transmission electron microscopy analysis. As
shown in Figure 4D-F, ARPE-19 cells exhibited well defined
parasitophorous vacuoles containing variable numbers of T.
gondii tachyzoites 60 and 240 min after initial infection.
Immunohistochemistry  studies  showed  ANXA1
localization in the nucleus and cytoplasm of ARPE-19 cells.
At 60 and 120 min after initial infection with T. gondii, an
intense  immunoreactivity  of  ANXA1  was  detected  in  the
nucleus and cytoplasm of infected cells compared to control
cells (Figure 5A-C). At 240 min and 24 h after infection, a low
level of ANXA1 expression was noted in these cells (Figure
5D,E). No labeling was detected in ARPE-19 cells incubated
with rabbit pre-immune serum (Figure 5F). Densitometric
analysis  revealed  that  T.  gondii  infection  significantly
augmented ANXA1 protein levels at 60 and 120 min after
infection, followed by a decrease at 240 min and 24 h after
infection (Figure 5G).
DISCUSSION
In this study we have investigated the ocular inflammatory
response  and  the  expression  pattern  of  anti-inflammatory
protein,  ANXA1,  in  inflammatory  and  retinal  pigment
epithelial (RPE) cells in in vivo and in vitro models of T.
gondii infection (RH strain).
Histopathological  studies  showed  that  the  intravitreal
inoculation of tachyzoites in mice provoked an intense influx
of inflammatory cells, especially neutrophils, in anterior (24
h)  and  posterior  (72  h)  eye  segments  with  consequent
destruction and disruption of the normal retinal architecture
and RPE vacuolization as compared to the control groups.
Similar observations were previously reported for mice that
were  intravitreally  inoculated  with  another  strain  of  T.
gondii (ME-49) [23], supporting the use of C57BL/6 mouse
as  a  reproducible  and  analogous  experimental  model  for
studying human ocular toxoplasmosis [25,26].
Our laboratory previously found that eyes infected with
T. gondii (RH strain) presented visible signs of mast cell
degranulation associated with inflammatory response [27].
Mast cells can release an array of potent mediators, which can
induce both rapid and delayed inflammatory response, thereby
promoting  leukocyte  recruitment,  contributing  to
development of eye diseases, including conjunctivitis, atopic
keratoconjunctivitis and uveitis [28-30]. Our data revealed
that the presence of parasites at 24, 48, and 72 h after initial
infection did not alter mast cell numbers as compared to in the
control group, although at 72 h after infection all mast cells
were  degranulated  in  the  anterior  eye  segment.  Previous
rodent  models  of  T.  gondii  (RH  strain),  intraperitonial
infection  found  degranulation  and  cytoplasmic  vacuoles
containing tachyzoites in peritoneal mast cells, suggesting
their  involvement  in  the  immune  response  to  T.  gondii
infection [31] through the release of potent mediators, such as
leukotriene B4 (LTB4) [32].
The  accumulation  and  subsequent  activation  of
leukocytes are central events in the inflammatory response.
Thus, the further elucidation of the molecular mechanisms
regulating leukocyte influx into inflamed tissues may provide
a  better  understanding  of  the  etiology  of  inflammatory
diseases, as well as important targets for anti-inflammatory
therapy [33]. The term “anti-inflammation” has been used to
describe  the  balance  between  pro  and  anti-inflammatory
mediators that work together to initiate, maintain, and finally
resolve inflammatory reactions. ANXA1, a protein of 37 kDa,
was  originally  identified  as  a  mediator  for  several  anti-
inflammatory  actions  of  glucocorticoids  [10].
Pharmacological  studies  with  ANXA1  demonstrated  its
effects on inflammatory cells, including mast cells [17,18],
neutrophils  [14]  and  eosinophils  [34].  Furthermore,  the
development  of  knockout  mice  for  ANXA1  [35]  and
ultrastructural  immunocytochemical  analysis  [14,36]  have
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1587Figure 2. Expression of ANXA1 in neutrophils after intravitreal inoculation of T. gondii. Neutrophils (arrows) from infected eyes showed a
strong immunoreactivity for ANXA1 in the cytoplasm as compared to control eyes after 24 (A and D), 48 (B and E), and 72 h (C and F).
Counterstain: Hematoxylin. Scale bars: 10 µm. G: Densitometric analysis of ANXA1 in neutrophils. Values (arbitrary units) are expressed
as the mean±SEM of sections analyzed from four mice/group. *p<0.01 versus the respective control group.
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1588Figure 3. Expression of ANXA1 in the retinal pigment epithelium (RPE) by ultrastructural analysis. Control group (A-C). Experimental
groups: 24 h (D and E), 48 h (F), and 72 h (G). A: Electron micrograph of RPE localized between a vessel (V) of the choriocapillaris and
light-sensitive outer segments of the photoreceptors (P). Marked vacuolization of the RPE (D) is observed after intravitreal inoculation of T.
gondii compared to the control group (B). ANXA1 immunogold labeling (arrows) in the cytosol, vacuoles and membrane of pigment granules
of RPE of control (C) and infected eyes after 24 h (E). Also, a significant proportion of ANXA1 immunoreactivity (arrows) observed in
infected eyes after 48 (F) and 72 h (G). No labeling was detected in the control section (H). Scale bars: 1 µm (A and D), 0.5 µm (B, C, E,
F, G, and H). Density of ANXA1 immunogold particles in RPE (I). Data are mean±SEM of 10 distinct cells analyzed from four mice per
group. **p<0.01 and ***p<0.001 versus control group.
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1589allowed for the better definition of roles played by endogenous
ANXA1 in several cellular functions, including phagocytosis,
migration, and synthesis of mediators [37,38].
Despite the extensive literature on the pharmacological
effects of ANXA1 and its mimetic peptides in the specific
responses in cells using in vitro and in vivo procedures [15,
39,40], few studies have linked this protein to intraocular
inflammation.
Immunohistochemical  studies  in  the  ocular  tissues
revealed  the  expression  of  ANXA1  in  the  neutrophils,
especially its localization in the cytoplasm. At 24, 48, and 72
h after intravitreal tachyzoite infection, a significant increase
in  ANXA1  levels  in  the  neutrophils  of  the  anterior  and
posterior eye segment was detected compared to control cells.
These data showed a modulation of the endogenous ANXA1
in  the  cells  that  transmigrated  to  the  inflammatory  sites,
suggesting a role for ANXA1 in the process of neutrophil
activation in this experimental infection model. In a model of
intraocular  inflammation  induced  by  carrageenin
administration in the rat paw, an increase in the endogenous
levels of ANXA1 in the neutrophils was associated with a
decrease in the migration of these cells in the latter phase of
the inflammation, suggesting a role for this protein in the
control of neutrophil activation and consequent migration and
contribution to the resolution of the inflammatory response
[41]. Several studies have observed this anti-migratory effect
of ANXA1 [42]. Immunocytochemical studies and in situ
hybridization  showed  that  the  expression  of  endogenous
ANXA1 increased in the plasma membrane of circulating
neutrophils  during  the  inflammatory  process  and  after
transmigration in the cytoplasm [14]. These data indicate that
the protein ANXA1 regulates the leukocyte transmigration
and  the  production  of  proinflammatory  mediators  in
neutrophils.  Recent  investigation  has  also  showed  that  in
ANXA1  null  mice,  the  inflammatory  process  induced  by
zymosan  exacerbated  leukocyte  transmigration  in  the
peritoneal cavity [22].
The changes in RPE and the segments of photoreceptors
represent important clinical aspects of ocular toxoplasmosis,
resulting in retinochoroiditis. Further, the destruction of the
Figure 4. Analysis of ARPE-19 cells after T. gondii infection by light and transmission electron microscopy. Non-infected (control; A) and
infected cells after 60 (B) and 240 min (C) with thin and long extensions (arrows). Intracellular parasites (arrowhead). Electron micrograph
of control ARPE-19 cells (D) and infected with parasitophorous vacuoles containing variable numbers of T. gondii tachyzoites (T) after 60
(E) and 240 min (F). N, nucleus. Scale bars: 25 µm (A), 10 µm (B, C), 1 µm (D-F).
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1590retina in the experimental ocular toxoplasmosis model, where intravitreal and i.p. routes were used to administer T. gondii
Figure 5. Immunohistochemistry for ANXA1 in ARPE-19 cells. ANXA1 immunostaining was detected in the nucleus and cytoplasm of
ARPE-19 cells (A-E). After 60 and 120 min of infection, an intense immunoreactivity of ANXA1 was detected in the infected cells (B and
C) as compared to control cells (A). In the later time points of infection (240 min and 24 h), decreased expression of ANXA1 was noted (D
and E). Absence of ANXA1 immunostaining in ARPE-19 cells incubated with pre-immune serum (F). Counterstain: Hematoxylin. Bars: 10
µm. G: Densitometric analysis of ANXA1. Values (arbitrary units) are expressed as the mean±SEM of sections analyzed from 10 cells/ group.
*p<0.001 versus the control group; #p<0.001 versus 60 min; +p<0.001 versus 120 min.
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1591(ME-49 strain) inoculation, was associated with the migration
of RPE cells proximal to the parasites in this tissue, suggesting
a role of RPE in the immune defense against infection [43].
Our ultrastructural immunocytochemistry data revealed
an overexpression of the anti-inflammatory ANXA1 protein
in RPE cells after 48 and 72 h infection by T. gondii. Based
on the relevance of functional characteristics of human RPE
cells to the inflammatory events [44], and due to the possible
compare and confirm the data obtained on rodent model in
vivo, we also monitored the expression of ANXA1 in the
human  RPE  (ARPE-19  cells)  in  experimental  conditions.
Interaction  of  these  cells  with  parasites  induced  ANXA1
expression, with a significant increase in its level after 60 and
120 min, followed by a decrease at later times (240 min and
24 h). Most studies investigating the effect of ANXA1 on
epithelial cells have identified an antiproliferative role [37]
and  few  of  them  discuss  this  role  during  inflammatory
processes. One such investigation showed increased promoter
activity of the ANXA1 gene in lung epithelial cells at 6 h after
induction  of  endotoxemia  in  mice.  This  activation  was
associated with the activity of these cells in controlling local
and systemic responses to LPS administration [21]. In chronic
inflammation, the expression of ANXA1 is also positively
modulated in human epithelial cells in nasal polyps cases after
treatment with glucocorticoids, suggesting an inhibitory role
of ANXA1 in epithelial proliferation, which is common to this
pathology [19]. Thus, the increased levels of ANXA1 in the
ARPE-19  cells  are  likely  for  cellular  activation  and  the
phagocytosis of the parasites, indicating an immune protective
role in the tissue.
In conclusion, our results demonstrated that intravitreal
infection of T. gondii in a murine model provoked an intense
inflammatory  response  characterized  by  leukocyte
accumulation in the ocular tissues and morphological changes
that  are  clinically  significant  in  the  retina  after  72  h  of
infection.  Further,  by  immunohistochemical  analyses,  we
showed for the first time, that the experimental infection by
T.gondii positively modulates the expression of ANXA1 in
the  neutrophils  and  RPE  cells  involved  in  the  intraocular
inflammatory responses, which may constitute an important
target for therapy studies in ocular toxoplasmosis.
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